Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma

Author:

Zhao Dong¹,Long Xi-Dai¹²,Lu Tian-Fei¹,Wang Tao¹,Zhang Wei-Wei³,Liu Yi-Xiao⁴,Cui Xiao-Lan¹,Dai Hui-Juan¹,Xue Feng¹,Xia Qiang¹

Affiliation:

1. Department of Liver Surgery; Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai China

2. Department of Pathology; Youjiang Medical College for Nationalities; Baise China

3. Department of Immunology; Changhai Hospital, the Second Military Medical University; Shanghai China

4. Department of Pathology; Guangxi Medical University; Nanning China

Funder

Innovation Program of Shanghai Municipal Education Commission

Shanghai Municipal Education Commission and Shanghai Education Development Foundation

the National Natural Science Foundation of China

the Natural Science Foundation of Guangxi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-22 in cancer;Medical Oncology;2024-09-05

2. Advance of Metformin in Liver Disease;Current Medicinal Chemistry;2024-01-30